COMPANY PROFILE

Latent Labs

Explore full profile

We are making biology programmable to transform health and sustainability for the benefit of all

London, United KingdomFounded 2023Biotech & Life Sciences

Valuation $100–250M Last recorded · 2025

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Latent Labs

We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering.

Read full description

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2023
Headquarters: London, United Kingdom
Employees: 22
Open positions: None listed
Dealroom signal: 88.5/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Core AI, Generative AI, AI Drug Discovery, genAI Model Maker, genAI Applications, Techbio
Technology: Artificial Intelligence, Deep Tech, Machine Learning
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES AOther financing	Feb 2025	$50M	$200M	Pillar VC · Flying Fish · Sofinnova Partners · 8VC	↗
SEEDOther financing	Sep 2023	$9.1M	$36M	8VC · Kindred Capital · Sequoia · Pillar VC	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Latent Labs website traffic

Latest recorded traffic for Latent Labs is 19K monthly website visits, up 18.8% over the last three months. Latent Labs's team grew 46.7% over the past year.

Latest monthly visits19K 3-month web change+18.8% 1-year team growth+46.7%

Monthly website visitsApr 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
RTRelation TherapeuticsUsing machine learning to improve drug discovery	London, United Kingdom	Operational	139	$139M	$220M
PCPeptone - The Protein Intelligence CompanyA translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins	London, United Kingdom	Operational
KUKuanoUsing machine learning and quantum physics to simulate, filter, and discover new molecules	Cambridge, United Kingdom	Operational
BEBenevolentAIBenevolentAI is a leading, clinical-stage AI-enabled drug discovery company	London, United Kingdom	Operational
ILIgnota LabsUsing cutting-edge AI algorithms to predict toxic endpoints, earlier in the drug discovery process	London, United Kingdom	Operational
CECellVoyantAn AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases	Bristol, United Kingdom	Operational
CACardiaTecApplying artificial intelligence on large-scale human multiomic data to develop the next generation of cardiovascular disease targets	Cambridge, United Kingdom	Operational
MHMultiomic HealthAI-enabled precision medicine for metabolic syndrome-related conditions	London, United Kingdom	Operational